Research Topics
Genomes and Genes | Jinru ShiaSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistryJinru Shia
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
J Mol Diagn 10:293-300. 2008....
Secondary mutation in a coding mononucleotide tract in MSH6 causes loss of immunoexpression of MSH6 in colorectal carcinomas with MLH1/PMS2 deficiencyJinru Shia
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Mod Pathol 26:131-8. 2013....
TNM staging of colorectal carcinoma: issues and caveatsJinru Shia
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Semin Diagn Pathol 29:142-53. 2012..The article also provides a brief discussion about some of the major adjunct histopathologic prognostic factors, such as medullary-type histology and tumor differentiation...
An update on tumors of the anal canalJinru Shia
Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
Arch Pathol Lab Med 134:1601-11. 2010..The anal canal possesses complex anatomy and histology and gives rise to a variety of tumor types. Challenging issues remain with regard to both the pathologic diagnosis and the clinical management of these tumors...
Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: how reliable are biopsy samples?Jinru Shia
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Am J Surg Pathol 35:447-54. 2011..However, whether biopsy samples can be reliably used for mismatch repair protein detection remains to be determined...
Metastatic epithelioid gastrointestinal stromal tumor: yet another tumor with anemone cell featuresJinru Shia
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ultrastruct Pathol 27:95-100. 2003....
Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significanceJinru Shia
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Hum Pathol 39:498-505. 2008..The significance of such an association as well as the prognostic value of FRalpha expression deserves further exploration...
Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasmsJinru Shia
Department of Pathology, Memorial Sloan Kettering, Cancer Center, New York, NY 10021, USA
Am J Surg Pathol 29:96-104. 2005....
Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experiencePatrick S Wolf
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
J Am Coll Surg 216:41-9. 2013..This study investigates the effect of preoperative chemotherapy for CRCLM on nontumoral liver histology and perioperative outcomes in a contemporary cohort...
Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery aloneAviram Nissan
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 24:4078-84. 2006..CONCLUSION Patients with T2-3, N0 rectal cancers and either lymphovascular invasion or elevated CEA levels have reduced survival and a higher incidence of PR, and should be considered for future randomized trials...
Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinomaSteven C Katz
Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Ann Surg 249:617-23. 2009..To determine if the degree of blood loss during resection of hepatocellular carcinoma (HCC) is predictive of recurrence and long-term survival...
Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panelJinru Shia
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Am J Surg Pathol 33:1639-45. 2009..Such a cost-effective approach carries significant implication, as immunohistochemistry is being widely used as first-line screening for HNPCC...
Response to neoadjuvant therapy in patients with early age-of-onset rectal cancerEmily Steinhagen
Department of Surgery, Colorectal Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Dis Colon Rectum 56:58-63. 2013..The response to neoadjuvant treatment in patients ≤ 50 years of age is not known. Factors affecting the response to neoadjuvant therapy in this age group have not been evaluated...
Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysisTobias Leibold
Department of Surgery Colorectal Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 18:2783-9. 2011..We prospectively evaluated tumor response with (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) early in the course of preoperative CRT...
Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapyTobias Leibold
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Room C 1077, New York, NY 10021, USA
J Clin Oncol 26:2106-11. 2008..The aim of this study was to examine the prognostic significance of location of involved lymph nodes in rectal cancer patients after preoperative chemoradiotherapy...
Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcomeGeorge A Poultsides
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 19:2797-804. 2012..Histologically, dominant response patterns include fibrosis, necrosis and/or acellular mucin, but some of these changes can appear without previous chemotherapy and their individual correlation with outcome is unknown...
Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiationHak Mien Quah
Department of Colorectal Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cancer 113:57-64. 2008....
Effects of obesity in rectal cancer surgeryHueylan Chern
Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
J Am Coll Surg 211:55-60. 2010..In this study, we evaluate whether higher body mass index (BMI) compromises surgical resection in patients with locally advanced, mid-to-low rectal cancer after neoadjuvant therapy, adversely affecting long-term oncologic outcomes...
Squamous-cell carcinoma of the anal canal: predictors of treatment outcomeRamin Roohipour
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Dis Colon Rectum 51:147-53. 2008..The incidence of anal canal squamous-cell carcinoma is increasing. Limited data exist on predictors of treatment failure. This study was designed to identify predictors for relapse/persistence after first-line therapy...
Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancerJinru Shia
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10002, USA
Am J Surg Pathol 27:1407-17. 2003..Using a stepwise logistic regression model, a formula was generated that could be used to calculate the probability of a colorectal carcinoma being MSI-H based on morphologic features...
Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosaRohit Bhargava
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer 106:1857-62. 2006..Either antibody may be used for immunohistochemical detection of EGFR in colorectal carcinomas. In addition, manual scoring had an excellent correlation with automated scoring...
Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcomeHarvey G Moore
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Room C-1077, New York, NY 10021, USA
Ann Surg Oncol 11:955-61. 2004..Expression of p27 in the residual rectal cancer may therefore identify patients with disease likely to be refractory to standard therapy and for whom investigational approaches should be strongly considered...
Rate of residual disease after complete endoscopic resection of malignant colonic polypJean M Butte
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Dis Colon Rectum 55:122-7. 2012..Following polypectomy, colectomy is performed selectively to ensure complete clearance of neoplasia...
A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonographyFrancesco Stipa
Department of Surgery-Colorectal Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Room C-1077, New York, New York 10021, USA
Ann Surg Oncol 13:1047-53. 2006..Because pCR seems to be associated with better outcome, an understanding of the factors governing the response to CMT should be pursued...
Limitations of early rectal cancer nodal staging may explain failure after local excisionRon G Landmann
Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Dis Colon Rectum 50:1520-5. 2007..The limitations of endorectal ultrasound in accurately staging nodal disease in early rectal lesions may, in part, explain the relatively high recurrence rates seen after local excision...
Squamous-cell carcinoma of the rectum: a rare but curable tumorCaio S R Nahas
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Dis Colon Rectum 50:1393-400. 2007..This study was designed to evaluate one institution's experience with treatment outcomes for rectal squamous-cell carcinoma...
Identification of patients with high-risk stage II colon cancer for adjuvant therapyHak Mien Quah
Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Dis Colon Rectum 51:503-7. 2008..The purpose of this study was to assess the prognostic significance of commonly reported clinicopathologic features of Stage II colon cancer to identify high-risk patients...
FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluationJeannine A Ruby
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Dis Colon Rectum 55:378-86. 2012..At present there is no defined role for routine FDG-PET in the preoperative evaluation of nonmetastatic rectal cancer...
A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinomaClifford S Cho
Hepatobiliary Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Am Coll Surg 206:281-91. 2008..Numerous staging systems have been devised for purposes of risk classification; we sought to identify the optimal staging system to predict postoperative survival...
Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancerJose G Guillem
Department of Surgery Colorectal Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Surg 241:829-36; discussion 836-8. 2005....
Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end pointJose G Guillem
Colorectal Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Room C 1077, New York, NY 10021, USA
J Clin Oncol 23:3475-9. 2005..However, because the accuracy of this approach has not been established, we conducted a prospective analysis to determine the operating surgeon's ability to assess response using DRE...
Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcomeJinru Shia
Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Am J Surg Pathol 28:215-23. 2004..Our results demonstrate distinct morphologic features in treated rectal carcinomas that are prognostically relevant...
Carcinoid of the rectum risk stratification (CaRRs): a strategy for preoperative outcome assessmentBridget N Fahy
Department of Surgery, Division of Colorectal Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Ann Surg Oncol 14:1735-43. 2007..Predicting rectal carcinoid behavior based exclusively on tumor size is imprecise. We sought to identify factors associated with outcome and incorporate them into a pre-operative risk stratification scheme...
Resection of adrenocortical carcinoma liver metastasis: is it justified?Sebastien Gaujoux
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 19:2643-51. 2012..Adrenocortical carcinoma (ACC) liver metastases (LM) represent a therapeutic challenge, and it is unclear whether resection is justified. This study assesses long-term outcome and prognostic factors after liver resection for metastatic ACC...
Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissectionMartin R Weiser
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Surg 249:236-42. 2009....
Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendixLaura H Tang
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Am J Surg Pathol 32:1429-43. 2008..Surgical management with right hemicolectomy is recommended after appendectomy for most cases, particularly those with an adenocarcinoma component (groups B and C)...
Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapyJinru Shia
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Am J Surg Pathol 35:127-34. 2011....
Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinomaIppolito Modica
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Am J Surg Pathol 31:744-51. 2007..In the future, as prognostic and therapeutic implications of MSI phenotype become better defined, it may be reasonable to perform IHC for mismatch repair proteins in large numbers of endometrial carcinomas...
A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservationJose G Guillem
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Ann Surg 245:88-93. 2007....
Surgical salvage of recurrent rectal cancer after transanal excisionMartin R Weiser
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Dis Colon Rectum 48:1169-75. 2005..This study examines surgical salvage of locally recurrent rectal cancer following transanal excision of early tumors...
Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective studyPeirong Ding
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Ann Surg 256:111-6. 2012..To characterize patterns of recurrence in locally advanced rectal cancer treated with combined modality therapy (CMT): neoadjuvant chemoradiation + total mesorectal excision + adjuvant chemotherapy...
Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapyAnand Govindarajan
Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
J Clin Oncol 29:4568-73. 2011..We sought to examine the feasibility and clinical significance of current guidelines on nodal assessment in patients with rectal cancer (RC) treated with neoadjuvant radiation...
Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinomaKui-Hin Liau
Hepatobiliary Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer 104:1948-55. 2005..Minimizing intraoperative blood loss appears to be critical for favorable long-term outcome in patients with large HCC...
Liver angiomyolipomas: a clinical, radiologic, and pathologic analysis of 22 patients from a single centerJean M Butte
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Surgery 150:557-67. 2011..The spectrum of presentation, imaging and histologic features, and outcomes were analyzed in all patients treated at Memorial Sloan-Kettering Cancer Center...
Predictive clinicopathologic factors for limited response of T3 rectal cancer to combined modality therapyAnne Y Lin
Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Colorectal Dis 23:243-9. 2008..The aim of this study was to identify pretreatment factors associated with poor tumor response to neoadjuvant chemoradiation...
Long-term survival after transanal excision of T1 rectal cancerGarrett M Nash
Department of Surgery, Colorectal Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Dis Colon Rectum 52:577-82. 2009..However, the impact of transanal excision on cancer mortality has not been adequately studied. The purpose of this study was to compare oncologic outcomes of transanal excision with those of radical resection...
A predictive model for lymph node yield in colon cancer resection specimensGarrett M Nash
Department of Surgery, Colorectal Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Ann Surg 253:318-22. 2011..To develop a predictive model of lymph node yield in a series of colon cancer resection specimens with detailed anatomic and surgical technique data...
Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical managementJose G Guillem
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Ann Surg 245:560-5. 2007..This study summarizes our initial experience with prospective, single-amplicon (mutation-specific) A636P testing in Ashkenazi Jewish patients at risk for Hereditary Nonpolyposis Colorectal Cancer (HNPCC)...
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?Jinru Shia
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Am J Surg Pathol 32:719-31. 2008..These tumors are clinically aggressive. Prospective studies using defined diagnostic criteria are needed to determine their biologic characteristics and optimal management...
DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non-triple-negative tumorsYong H Wen
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Am J Surg Pathol 36:1700-8. 2012....
Whole-mount pathologic analysis of rectal cancer following neoadjuvant therapy: implications of margin status on long-term oncologic outcomeJames J Mezhir
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Ann Surg 256:274-9. 2012..We set out to determine the long-term oncologic impact of resection margins in patients with locally advanced rectal cancer using a comprehensive pathologic whole-mount section analysis...
Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significanceMichael D'Angelica
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Mod Pathol 24:1221-8. 2011..The prognostic value of FRα expression and the utility of FRα-targeted therapies in stage-IV colorectal cancer patients deserve further exploration...
Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization studyJinru Shia
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Mod Pathol 18:1350-6. 2005..Additional studies are needed to determine whether epidermal growth factor receptor gene amplification bears any informative value in predicting response to cetuximab-based therapy...
Malignant mesothelioma with a pronounced myxoid stroma: a clinical and pathological evaluation of 19 casesJinru Shia
Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Virchows Arch 447:828-34. 2005..Our study emphasizes the need for better attention to histologic subtypes, particularly in the context of prognostically or therapeutically oriented investigations of this lethal disease...
Individualized prediction of colon cancer recurrence using a nomogramMartin R Weiser
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Clin Oncol 26:380-5. 2008..Although easy to implement, there remains significant heterogeneity within each stage grouping. In the era of multimodality treatment, a more refined tool is needed to predict recurrence...
Early postoperative intraperitoneal chemotherapy following cytoreductive surgery for appendiceal mucinous neoplasms with isolated peritoneal metastasisPatrick L Wagner
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Dis Colon Rectum 55:407-15. 2012..At our institution, patients undergoing complete cytoreduction in this setting typically receive multiple cycles of early postoperative intraperitoneal chemotherapy...
Improved testing for microsatellite instability in colorectal cancer using a simplified 3-marker assayIyare Esemuede
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 17:3370-8. 2010..However, the optimal assay for MSI status is unknown. We have evaluated a simplified 3-marker assay for MSI and compared it with the 5-marker (NCI) assay to see if technical variations in MSI testing are important...
Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significanceAnne Lin
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Hum Pathol 38:850-6. 2007..Further investigation on interaction between AMACR and other known colorectal cancer development pathways may provide new insights on colorectal carcinogenesis...
Pathologic complete response to neoadjuvant FOLFOX in combination with bevacizumab in unresectable metastatic colorectal carcinomaAustin Duffy
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Clin Colorectal Cancer 7:140-3. 2008..He underwent hepatic metastasectomy and was found to have had a complete pathologic response (pCR) to treatment. The literature regarding pCR with chemotherapy in CRC and the implications for further management is discussed herein...
The role of abdominoperineal resection as surgical therapy for anorectal melanomaJen Jen Yeh
Memorial-Sloan Kettering Cancer Center, New York, NY 10021, USA
Ann Surg 244:1012-7. 2006..Therefore, LE of the primary tumor is recommended when technically feasible. The presence of PNI is an important prognostic factor and should be considered in future clinical trials...
Collision tumor of the large bowel in the context of advanced pregnancy and ulcerative colitisAustin Duffy
Deparment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Clin Colorectal Cancer 7:402-5. 2008..Platinum-based chemotherapy resulted in a divergent pathologic response as assessed after colectomy. The diagnosis and classification of mixed endocrine-exocrine tumors of the colon are discussed, along with treatment considerations...
Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literatureYevgeniy Karamurzin
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Hum Pathol 43:1677-87. 2012..As yet, however, there are no data to support the inclusion of these tumors into general screening guidelines for detecting Lynch syndrome, nor are there data to warrant surveillance for these tumors in patients with Lynch syndrome...
High-grade dysplasia of the cystic duct margin in the absence of malignancy after cholecystectomyKai A Bickenbach
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
HPB (Oxford) 13:865-8. 2011..A total of 750,000 cholecystectomies are performed annually in the USA. No data exist on patients with microscopic high-grade dysplasia at the cystic duct margin and the associated incidence of cholangiocarcinoma...
Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysisAxel Hoos
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 8:3841-9. 2002..However, down-regulation of p27 appears to be associated with a trend toward reduced DFS and DSS, which suggests further investigation of other p27-related pathways potentially relevant for metastatic disease...
Carcinoid of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessmentBridget N Fahy
Department of Surgery, Division of Colorectal Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Ann Surg Oncol 14:396-404. 2007..Predicting rectal carcinoid behavior exclusively on the basis of tumor size is imprecise. We sought to identify factors associated with outcome and incorporate them into a preoperative risk stratification scheme...
Feasibility of ex vivo FDG PET of the colonMarc J Gollub
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10023, USA
Radiology 252:232-9. 2009....
Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancyMaeve A Lowery
Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Oncologist 16:1714-20. 2011..We present a series of 40 consecutive cases of ACC of the pancreas treated at Memorial Sloan-Kettering Cancer Center, with an emphasis on evaluation of activity of new therapeutic agents...
DNA mismatch repair deficiency in ampullary carcinoma: a morphologic and immunohistochemical study of 54 casesNarasimhan P Agaram
Dept of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
Am J Clin Pathol 133:772-80. 2010..Typical MSI-high histologic features of CRC, such as increased TIL counts, seem to have similar yet subtly different implications in ampullary carcinoma...
Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancerDiane Lauren Reidy
Department of Medicine, Division of Solid Tumors, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Howard 1004, New York, NY 10065, USA
J Clin Oncol 28:4240-6. 2010....
KRAS mutation correlates with accelerated metastatic progression in patients with colorectal liver metastasesGarrett M Nash
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 17:572-8. 2010..To examine more directly whether KRAS mutations are associated with accelerated metastatic progression, we evaluated KRAS mutation as well as Ki-67 expression in patients with colorectal liver metastases not treated with cetuximab...
Response of stage IV anal mucosal melanoma to chemotherapyJen Jen Yeh
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Lancet Oncol 6:438-9. 2005
The utility of immunohistochemical detection of DNA mismatch repair gene proteinsJinru Shia
Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, NY 10021, New York, USA
Virchows Arch 445:431-41. 2004....
T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastasesSteven C Katz
Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 16:2524-30. 2009..This study examines the correlation between TIL numbers and survival following hepatic resection...
Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 casesWilbur B Bowne
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Dis Colon Rectum 48:897-909. 2005..Complete resection is critical to long-term survival and is associated with a single site of recurrence, perianastomotic disease, low presalvage carcinembryonic antigen level, and absence of distant disease...
Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resectionHarvey G Moore
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Dis Colon Rectum 47:279-86. 2004....
Immunoblot analysis of c-Met expression in human colorectal cancer: overexpression is associated with advanced stage cancerZhaoshi Zeng
Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Clin Exp Metastasis 21:409-17. 2004..C-Met protein is expressed at levels significantly higher than adjacent mucosa in most primary adenocarcinomas of the colon. Our results support an important role for c-Met in human CRC progression and metastasis...
Defining surgical indications for type I gastric carcinoid tumorRebecca A Gladdy
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 16:3154-60. 2009..The management of this indolent disease is controversial. The aim of this study was to evaluate endoscopic surveillance (ES) compare with surgical resection (SR) for type I GC...
MSH6 germline mutations are rare in colorectal cancer familiesPaolo Peterlongo
Cell Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Cancer 107:571-9. 2003..Altogether, our results indicate that disease-causing germline mutations of MSH6 are rare in HNPCC and HNPCC-like families...
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistryKi Young Chung
Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, H 816, New York, NY 10021, USA
J Clin Oncol 23:1803-10. 2005....
Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathologic study of 26 casesJinru Shia
Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, U.S.A
Am J Surg Pathol 26:216-24. 2002..The estimated 5-year disease-free survival was 62%, and median disease-free survival was 69 months. The estimated 5-year relapse-free survival was 54%, and the median relapse-free survival was 63 months...
A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patientsGary Deng
Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, United States
J Ethnopharmacol 136:83-7. 2011..We conducted a phase II trial of SST in hepatitis C patients who were not candidates for interferon-based therapy to determine whether this agent is worthy of further study...
Scirrhous metastases to the gastrointestinal tract at CT: the malignant target signMarc J Gollub
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Room C276F, New York, NY 10021, USA
AJR Am J Roentgenol 192:936-40. 2009..CONCLUSION: Twenty-five patients with scirrhous metastases had a malignant CT target sign. Careful observation and correlation with clinical history are required to differentiate this unique sign from a benign target sign...
Variable MR imaging appearances of focal nodular hyperplasia in pediatric cancer patientsRichard K G Do
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
Pediatr Radiol 41:335-40. 2011..FNH can be incidentally found on CT and MRI and can be misdiagnosed as liver metastasis in patients with an oncological history...
HER 2/neu expression and gene amplification in colon cancerDaniel R Nathanson
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Int J Cancer 105:796-802. 2003..These data indicate that the primary mechanism of dysregulated HER 2/neu expression in colon cancer, as in breast cancer, is gene amplification...
An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancerDeborah Schrag
Memorila Sloan-Kettering Cancer Center, New York, NY, USA
J Clin Oncol 23:1799-802. 2005
Resection of hepatocellular carcinoma in patients otherwise eligible for transplantationCharles H Cha
Hepatobiliary Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Ann Surg 238:315-21; discussion 321-3. 2003..Resection should be considered the standard therapy for patients with HCC who have adequate liver reserve...
Pancreatic islet cell carcinoma presenting with concurrent Cushing's and Zollinger-Ellison syndromes: case series and literature reviewRabih Said
Staten Island University Hospital, New York, USA
Eur J Gastroenterol Hepatol 22:246-52. 2010..As the data confers a worse prognosis versus other pancreatic neuroendocrine tumors, the relatively favorable outcome of the two patients reported herein may reflect the impact of multiple therapeutic modalities...
Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection?Francesco Stipa
Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Ann Surg Oncol 11:187-91. 2004....
Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcomeUdai S Kammula
Surgery Branch, National Cancer Institute, Bethesda, MD, USA
Cancer Lett 248:219-28. 2007..We hypothesize that over-expression of the c-Met receptor and its ligand, hepatocyte growth factor (HGF) in the tumor microenvironment is associated with tumor progression and metastases...
Expression of P53, P27 and KI-67 in colorectal cancer patients of various ethnic origins: clinical and tissue microarray based analysisTzeela Cohen
Department of Surgery, Hadassah Hebrew University Medical Center, Jerusalem, Israel
J Surg Oncol 97:416-22. 2008..This study was conducted to determine survival according to the expression of molecular markers in colorectal cancer (CRC) patients of various ethnic origins...
GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1Yu Wen
Robert Wood Johnson Medical School and Cancer Institute of New Jersey, New Brunswick, New Jersey 08903, USA
Clin Cancer Res 12:5951-9. 2006..We found that the mRNA and protein products of GROalpha are more highly expressed in neoplastic than normal colon epithelium, and we studied potential mechanisms by which GROalpha may contribute to tumor initiation or growth...
Relationship of gene expression and chromosomal abnormalities in colorectal cancerDafna Tsafrir
Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot, Israel
Cancer Res 66:2129-37. 2006....
Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapySilke Lassmann
Institute of Pathology, University Hospital, Albert Ludwigs University Freiburg, Freiburg, Germany
Gastroenterology 133:1831-9. 2007....
Lymph node metastasis in T1 adenocarcinoma of the colon and rectumSatoshi Okabe
Department of Surgery, Tokyo Medical and Dental University, Tokyo, Japan
J Gastrointest Surg 8:1032-9; discussion 1039-40. 2004..In early colorectal cancers, tumor morphology is the strongest clinical predictor of metastatic behavior...
Intramucosal poorly differentiated colorectal carcinoma: can it be managed conservatively?Jinru Shia
Am J Surg Pathol 32:1586-8; author reply 1588-9. 2008
Extranodal follicular dendritic cell sarcoma: clinical, pathologic, and histogenetic characteristics of an underrecognized disease entityJinru Shia
Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Virchows Arch 449:148-58. 2006..The 5-year recurrence-free survival was 27.4%. From data available at the current time, we were not able to identify prognostically significant pathologic factors...
Distinction of endometrial stromal sarcomas from 'hemangiopericytomatous' tumors using a panel of immunohistochemical stainsRohit Bhargava
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Mod Pathol 18:40-7. 2005..We therefore recommend the use of a small antibody panel comprising anti-CD10, anti-estrogen receptor, and anti-CD34 to distinguish endometrial stromal sarcomas from tumors with a predominant hemangiopericytomatous growth pattern...
The signatures of autozygosity among patients with colorectal cancerManny D Bacolod
Department of Microbiology, Weill Medical College of Cornell University, New York, NY 10021, USA
Cancer Res 68:2610-21. 2008....
Preoperative radiographic assessment of hepatic steatosis with histologic correlationClifford S Cho
Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792 7375, USA
J Am Coll Surg 206:480-8. 2008..But the accuracy of preoperative radiologic assessment of fatty liver disease remains unclear. The objective of this study was to correlate preoperative radiologic estimation with postoperative histologic measurement of steatosis...
The activity of sunitinib against gastrointestinal stromal tumor seems to be distinct from its antiangiogenic effectsMarco Seandel
Clin Cancer Res 12:6203-4. 2006
BLM heterozygosity and the risk of colorectal cancerStephen B Gruber
Departments of Internal Medicine and Epidemiology, University of Michigan, Ann Arbor, MI 48109, USA
Science 297:2013. 2002
